GlassScriptPhysician profile
Mark J Veronneau
NPI 1932208899
$961.59
in general payments reported to CMS, 2019-2025
19 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $141 · 2021: $198 · 2022: $107 · 2023: $80.11 · 2024: $179 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $150.49 | 2019-2024 | |
| Optinose US, INC. | $144.01 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $135.79 | 2021-2024 | Dupixent |
| Stryker Corporation | $86.95 | 2019-2024 | Na, Smartlock, Stryker Varispeed |
| Glaxosmithkline, LLC. | $85.45 | 2019-2024 | Nucala |
| Kls-Martin L.P. | $46.41 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $35.15 | 2025 | Tecnis Iol |
| Amgen INC. | $34.74 | 2022-2025 | |
| Inspire Medical Systems, INC. | $33.89 | 2025 | Inspire |
| Ethicon US, LLC | $31.79 | 2019 | |
| Alk-Abello, INC | $29.13 | 2019-2021 | |
| Ambu INC. | $28.05 | 2023 | |
| Merck Sharp & Dohme LLC | $25.30 | 2025 | Keytruda |
| Integra Lifesciences Corporation | $21.67 | 2020 | |
| Allergan, INC. | $18.27 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $15.79 | 2024 | Voquezna |
| Rxsight INC | $15.41 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Uswm, LLC | $12.39 | 2021 | |
| Galderma Laboratories, L.P. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Veronneau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.